Chimera (CIM) CEO receives 194,774 RSU-linked common shares

Rhea-AI Filing Summary

Chimera Investment Corporation’s President and CEO, Phillip John Kardis II, reported an equity award of 194,774 shares of common stock on January 20, 2026. These shares represent restricted stock units (RSUs), each economically equal to one share of Chimera common stock, granted at a price of $0 per share as part of compensation.

The RSUs are scheduled to vest in three equal installments on December 31, 2026, 2027 and 2028, and will be settled entirely in Chimera common stock. Following this grant, Kardis beneficially owns 695,495 shares of Chimera common stock directly, which also include dividend equivalent rights tied to prior RSUs and performance stock units.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kardis Phillip John II

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	194,774	$0.00	--

Holdings After Transaction: Common Stock — 695,495 shares (Direct)

Footnotes (1)

1. Represents shares of Chimera Investment Corporation ("Chimera") common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on December 31st of 2026, 2027 and 2028 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. Each RSU is the economic equivalent of one share of Chimera common stock. Dividend equivalent rights ("DERs") issued on RSUs and underlying performance stock units or PSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kardis Phillip John II

(Last) (First) (Middle)

C/O: CHIMERA INVESTMENT CORPORATION

630 FIFTH AVENUE, SUITE 2400

(Street)

NEW YORK NY 10111

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHIMERA INVESTMENT CORP [ CIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/20/2026		A		194,774(1)	A	$0(2)	695,495(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Chimera Investment Corporation ("Chimera") common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on December 31st of 2026, 2027 and 2028 and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

2. Each RSU is the economic equivalent of one share of Chimera common stock.

3. Dividend equivalent rights ("DERs") issued on RSUs and underlying performance stock units or PSUs are included in the reporting person's common stock holding balance. Each DER is the economic equivalent of one share of Chimera common stock.

Remarks:

	/s/ Phillip John Kardis II	01/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Chimera Investment Corp (CIM) report for its CEO?

Chimera reported that President and CEO Phillip John Kardis II received an award of 194,774 shares of common stock on January 20, 2026, in the form of restricted stock units (RSUs) granted at $0 per share.

How do the RSUs granted to the Chimera (CIM) CEO vest?

The RSUs granted to the CEO are scheduled to vest one-third per year on December 31, 2026, December 31, 2027 and December 31, 2028, and will be settled entirely in shares of Chimera common stock.

How many Chimera Investment Corp (CIM) shares does the CEO own after this Form 4 transaction?

After the reported transaction, President and CEO Phillip John Kardis II beneficially owns 695,495 shares of Chimera Investment Corp common stock directly.

What is the economic relationship between the RSUs and Chimera (CIM) common stock?

Each restricted stock unit (RSU) is described as the economic equivalent of one share of Chimera common stock, and will be settled 100% in common shares upon vesting.

What are dividend equivalent rights (DERs) mentioned in the Chimera (CIM) CEO filing?

Dividend equivalent rights (DERs) issued on RSUs and performance stock units are included in the CEO’s common stock holding balance, and each DER is also the economic equivalent of one share of Chimera common stock.

Does the Chimera (CIM) CEO plan to report future RSU vesting events separately?

The filing states that the reporting person does not intend to report the vesting of the RSUs or the delivery of the corresponding shares of common stock.